Toll-like receptor-dependent discrimination of streptococci
- 1 October 2006
- journal article
- other
- Published by SAGE Publications in Innate Immunity
- Vol. 12 (5), 307-312
- https://doi.org/10.1177/09680519060120050601
Abstract
Streptococcus pneumoniae and Streptococcus agalactiae cause distinct infectious diseases in small children. Similarly, these bacteria elicit very different host-cell responses in vitro. Inactivated S. agalactiae by far exceeds S. pneumoniae in the activation of inflammatory cytokines and upstream signaling intermediates such as the MAP kinase JNK. The inflammatory response to both Streptococcus spp. is mediated by MyD88, an essential adapter protein of Toll-like receptors (TLRs), although the specific TLRs that are involved have not been fully resolved. Furthermore, during logarithmic growth, S. pneumoniae releases pneumolysin that interacts with TLR4 whereas S. agalactiae releases diacylated molecules that interact with TLR2/6. Interaction of these soluble bacterial products with their cognate TLRs is critical for limiting bacterial dissemination and and systemic inflammation in mice. This might be due, in part, to TLR-mediated apoptosis induced by these factors. In conclusion related streptococcal species induce specific events in TLR-mediated signal transduction. Comparative analysis of the host-cell response to these bacteria reveals molecules such as JNK as valuable targets for adjunctive sepsis therapy.Keywords
This publication has 50 references indexed in Scilit:
- Emergence of Vaccine-Related Pneumococcal Serotypes as a Cause of BacteremiaClinical Infectious Diseases, 2006
- Pathogen Recognition and Innate ImmunityCell, 2006
- Host and Bacterial Factors Contributing to the Clearance of Colonization byStreptococcus pneumoniaein a Murine ModelInfection and Immunity, 2005
- The Apoptotic Response to Pneumolysin Is Toll-Like Receptor 4 Dependent and Protects against Pneumococcal DiseaseInfection and Immunity, 2005
- Bacterial programmed cell death of cerebral endothelial cells involves dual death pathwaysJournal of Clinical Investigation, 2005
- Use of Type V Group B Streptococcal Conjugate Vaccine in Adults 65–85 Years OldThe Journal of Infectious Diseases, 2004
- Monocytes Stimulated with Group B Streptococci or Interferons Release Tumour Necrosis Factor‐Related Apoptosis‐Inducing LigandScandinavian Journal of Immunology, 2004
- Role ofToll-Like Receptor 4 in Gram-Positive and Gram-Negative Pneumonia inMiceInfection and Immunity, 2004
- Nod1 Detects a Unique Muropeptide from Gram-Negative Bacterial PeptidoglycanScience, 2003
- Active Bacterial Core Surveillance of the Emerging Infections Program NetworkEmerging Infectious Diseases, 2001